B · Normal
[Rongchang Bio: Signed an amendment to the RC298 license agreement with Vor Bio and received a down payment of approximately US$56 million] On November 12, Rongchang Bio (688331.SH) announced that the company and Vor Bio had signed an amendment to the existing license agreement to include the independently developed RC298 within the scope of cooperation. VorBio will obtain exclusive global development and commercialization rights for the product outside Greater China. The company will receive an upfront payment worth approximately US$56 million, including US$10 million in cash and warrants worth approximately US$46 million, and will be eligible to receive development milestone payments of up to US$300 million.
A-share announcement express 🕐 2026-11-12 20:39
#A-share announcement express
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Hainan Mining: The issue of issuing shares to purchase assets was suspended for 11-12 21:53 [2-plate Zhongzhong Technology: No sales revenue related to the humanoid robot b 11-12 19:39 [Qizhong Technology: Plans to raise no more than 2 billion yuan for multi-core h 11-12 19:38 [Hengyi Petrochemical: Plans to acquire 51% of Shaoxing Hengming’s equity for RM 11-12 19:22 [Lingyi Intelligent Manufacturing: Plans to increase capital of RMB 816 million 11-12 19:16 [Tianci Materials: Plans to repurchase shares between 50 million and 100 million 11-12 19:12

Comments

0/500
Captcha (click to refresh)
No comments yet